Review of quercetin in metabolic diseases shows promise but lacks clinical validation.
Review suggests quercetin may have multiple beneficial effects on metabolic conditions
This review evaluates quercetin for conditions including diabetes, obesity, and gout. While the medication demonstrates favorable human tole…
A natural compound found in fruits and vegetables shows promise for managing type 2 diabetes, obesity, and fatty liver disease, though human…
Systematic review examines lipid-immune crosstalk and dyslipidemia in rheumatoid arthritis patients.
The Hidden Link Between Arthritis Pain and Your Heart Health
This systematic review evaluated epidemiological evidence, clinical management strategies, and pathophysiological mechanisms regarding lipid…
Abnormal cholesterol is a direct driver of rheumatoid arthritis, explaining why people with RA face such a high risk of heart attack and str…
CHIP mutations increase cardiovascular risk and mortality in older adults independent of traditional factors.
Your Aging Blood Cells May Be Quietly Attacking Your Heart
This review synthesizes evidence regarding clonal hematopoiesis of indeterminate potential (CHIP) in individuals older than 70 years. Findin…
Aging blood cell mutations called CHIP quietly raise heart attack risk by fueling inflammation, affecting over 10% of adults over 70.
Systematic review identifies shared immune mechanisms and therapeutic targets across cardiovascular inflammatory diseases
Could one immune problem be driving three different heart conditions?
A systematic review examined shared immunological mechanisms across atherosclerosis, myocarditis, and vasculitis. It identified CXCR4, PYCAR…
Three different heart diseases might share one immune trigger, suggesting new ways to treat plaque buildup, heart muscle inflammation, and b…
Reduced anti-CXCR3 antibodies associated with systemic autoimmunity and atherosclerosis in cohort study
Study finds link between specific antibody levels and heart disease risk in autoimmune conditions
An observational cohort study of patients with rheumatoid arthritis, Sjogren disease, and controls found reduced anti-CXCR3 antibody levels …
Low levels of a specific antibody in early arthritis and joint pain are linked to higher heart disease risk and poorer medication responses.